Posted On: 01/19/2015 7:36:45 PM
Post# of 30066
what's in Boston
Dr. Lowe served as the Executive Vice President and Chief Scientific Officer at Fidelity Biosciences Group, Fidelity Investments in Boston, MA, an investment firm focused on the healthcare industry. He also served as President, CEO and Director of Envivo Pharmaceuticals, a Fidelity-funded pharmaceutical company pursuing new treatments for AZ disease, now in Phase 3 development.
Amarantus established a research collaboration with researchers at Boston University School of Medicine. The Company is working together with Boston University School of Medicine Professor of Neurology and Neurosurgery Dr. Robert Stern to evaluate the feasibility of using the LymPro Test ® as a blood based test to identify patients early in the disease process of the neurodegenerative diseases, Chronic Traumatic Encephalopathy (CTE) and Alzheimer's disease.
Dr. Lowe served as the Executive Vice President and Chief Scientific Officer at Fidelity Biosciences Group, Fidelity Investments in Boston, MA, an investment firm focused on the healthcare industry. He also served as President, CEO and Director of Envivo Pharmaceuticals, a Fidelity-funded pharmaceutical company pursuing new treatments for AZ disease, now in Phase 3 development.
Amarantus established a research collaboration with researchers at Boston University School of Medicine. The Company is working together with Boston University School of Medicine Professor of Neurology and Neurosurgery Dr. Robert Stern to evaluate the feasibility of using the LymPro Test ® as a blood based test to identify patients early in the disease process of the neurodegenerative diseases, Chronic Traumatic Encephalopathy (CTE) and Alzheimer's disease.
(0)
(0)
